Download our press release published on 8 November to find out the financial results for the first nine months of 2017.
0 min
08 Nov, 2017
Operating income, growth figures, profitability and how our products have behaved.
0 min
08 Nov, 2017
The fast onset of action long-acting injectable of risperidone. Based on our ISM® patented technology.
0 min
25 Oct, 2017
Learn about the financial results of the first half of 2017 by downloading our press release published on July 26.
0 min
26 Jul, 2017
Operating revenues, growth data, profitability and the behavior of our products.
0 min
26 Jul, 2017
The biosimilar Enoxaparin
1 min
13 Mar, 2017
